Treatment of HYpertension: Morning Versus Evening

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT02214498

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02214498
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02214498. Randomized; quadruple masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2017-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Treatment of HYpertension: Morning Versus Evening
Acronym
THYME
Condition
Essential Hypertension
Intervention (Drug)
Enalapril/hydrochlorothiazide
Intervention (Drug)
Placebo
Lead sponsor
Erasmus Medical Center (class: other)
Collaborator
ZonMw: The Netherlands Organisation for Health Research and Development (class: other)

Record details

Record id
cardio:ct-nct02214498
Content hash
94fe325f1145348f354f366e1390d4f14e4f3934edc490498fc77ae78bf4762b